Our official journals publish cutting-edge research and best practice in endocrinology, contributing to our key aim of promoting advances in the field.

PUBLISH WITH GREATER IMPACT!

The latest Journal Citation Reports^TM were announced in the summer and it’s great news for your Society journals.

Journal of Endocrinology has seen a substantial increase in Journal Impact Factor from 4.286 to 4.669, with the Five-Year measure also increasing to its best-ever score at 5.533. The journal now ranks 57 out of 146 journals in the ‘Endocrinology and Metabolism’ category.

Endocrine-Related Cancer has an increase in Impact Factor to 5.900. The journal now ranks 35 out of 146 journals in the ‘Endocrinology and Metabolism’ category, and also 72 out of 245 in the ‘Oncology’ category.

Journal of Molecular Endocrinology has achieved an Impact Factor of 4.869, ranking 50 out of 146 journals in the ‘Endocrinology and Metabolism’ category. The Five-Year Impact Factor has increased to its highest-ever level at 5.532.

Endocrine Connections has received an Impact Factor of 3.221, with the Five-Year Impact Factor rising to 3.635. The journal ranks 101 out of 146 journals in its category.

Clinical Endocrinology received an Impact Factor of 3.522, ranking 93 out of 146 journals in the ‘Endocrinology and Metabolism’ category.

Journal Impact Factors are calculated by Web of Science and published each year in the Journal Citation Reports. They are often used as a tool for evaluating a journal’s quality. The 2021 Impact Factor takes into account citations in 2021 for papers published in 2019 and 2020.

The Society’s owned publications, Journal of Endocrinology, Journal of Molecular Endocrinology, Endocrine-Related Cancer and Endocrine Connections are published by our wholly owned trading subsidiary, Bioscientifica, which redistributes its profits back to the Society.

The Society would like to thank our Editorial Boards, authors and reviewers for their tremendous hard work and dedication, and all of our journal readers who use and cite articles. Together, you ensure that the Society’s journals continue to be influential publications that help us to advance scientific and clinical research in endocrinology for the public benefit – one of the Society’s key aims.

Members enjoy free online access to our subscription journals through the Members’ Area of our website, and benefit from reduced rates on print subscriptions and discounts on open-access publication fees.

Learn more about online access to our journals and review the new impact factors at www.endocrinology.org/publications.

CONGRATULATIONS TO OUR 2022 JOURNAL AWARD WINNERS!

Our Journal Awards recognise authors for excellence in research focus and practice and their contribution to the wider biomedical field. The highest ranked papers from each of the Society-owned journals are reviewed by the Editorial Boards to select the winning articles. The awards will be presented to the article authors at SfE BES 2022.

Journal of Endocrinology
Early or delayed time-restricted feeding prevents metabolic impact of obesity in mice – Prashant Regmi et al.

“We demonstrated the modification of peripheral circadian rhythm by meal time as a strategy for the prevention and therapy of obesity and associated metabolic disorders."

Journal of Molecular Endocrinology
Diversification of mineralocorticoid receptor genes in a subterranean rodent, the naked mole-rat – Kaori Oka et al.

“It’s a great honour to receive the Society Journal Award. I hope that you will be interested in the mysterious endocrine system of naked mole-rats with various attractive features."

Endocrine-Related Cancer
Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma – Luise Eckardt et al.

“Our research has shed light on the developmental origins of inherited cancers carrying mutations in the HIF pathway. This work has important implications for clinical strategies to prevent or treat these rare cancers, and we are honoured that our work has been recognised with this award."

Endocrine Connections
Phaeochromocytomas overexpress insulin transcript and produce insulin – Ivar Følling et al.

“The award came as a big surprise. The article describes primarily basic science, presenting new details of the biology of tumours in the adrenal medulla. In addition we discuss possible clinical implications of our findings.

Clinical Endocrinology
Cardiac phenotype in familial partial lipodystrophy – Abdelwahab Jalal Eldin et al.